See more : HLE Glascoat Limited (HLEGLAS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of PacificHealth Laboratories, Inc. (PHLI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PacificHealth Laboratories, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- MAG Silver Corp. (MAG) Income Statement Analysis – Financial Results
- Kangqiao Service Group Limited (2205.HK) Income Statement Analysis – Financial Results
- Choom Holdings Inc. (CHOOF) Income Statement Analysis – Financial Results
- Uvre Limited (UVA.AX) Income Statement Analysis – Financial Results
- Zhejiang Asia-Pacific Mechanical & Electronic Co.,Ltd (002284.SZ) Income Statement Analysis – Financial Results
PacificHealth Laboratories, Inc. (PHLI)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.pacifichealthlabs.com
About PacificHealth Laboratories, Inc.
PacificHealth Laboratories, Inc. engages in the development of nutritional products that enhance health and athletic performance in the United States and internationally. It primarily focuses on sports performance, hydration, fueling, and muscle recovery. The company provides ENDUROX R4, a muscle recovery drink; ACCELERADE protein powered sports drink; ACCEL GEL, a energy gel; Body Glove Surge; ENDUROX EXCEL, an exercise supplement; and 2ND SURGE, an ultra energy gel. It also offers ACCELERADE HYDRO for less intense workouts use before, during, and after workouts for hydration, energy, and recovery. The company markets its products to various distribution channels, including sports specialty and natural product retailers and chains, as well as markets their products through its Website. PacificHealth Laboratories, Inc. was founded in 1995 and is based in Matawan, New Jersey.
| Metric | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.91M | 7.20M | 8.00M | 7.24M | 7.43M | 6.21M | 5.44M | 6.81M | 5.45M | 5.12M | 6.15M | 3.84M | 2.10M | 1.00M | 3.40M | 3.10M |
| Cost of Revenue | 3.93M | 4.04M | 4.77M | 4.21M | 4.89M | 3.47M | 3.50M | 4.28M | 2.80M | 3.77M | 2.59M | 1.77M | 900.00K | 600.00K | 1.40M | 800.00K |
| Gross Profit | 2.99M | 3.16M | 3.22M | 3.02M | 2.54M | 2.74M | 1.94M | 2.53M | 2.65M | 1.36M | 3.55M | 2.07M | 1.20M | 400.00K | 2.00M | 2.30M |
| Gross Profit Ratio | 43.20% | 43.93% | 40.29% | 41.80% | 34.23% | 44.07% | 35.66% | 37.15% | 48.67% | 26.47% | 57.84% | 53.98% | 57.14% | 40.00% | 58.82% | 74.19% |
| Research & Development | 47.38K | 4.00K | 0.00 | 150.77K | 211.08K | 196.02K | 195.24K | 144.96K | 231.65K | 165.51K | 106.09K | 222.73K | 200.00K | 100.00K | 0.00 | 0.00 |
| General & Administrative | 2.16M | 2.75M | 3.20M | 3.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.26M | 1.17M | 1.88M | 898.91K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.41M | 3.92M | 5.08M | 4.44M | 3.60M | 2.92M | 3.72M | 4.62M | 3.78M | 3.73M | 3.07M | 3.14M | 2.80M | 2.90M | 6.20M | 2.20M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.46M | 3.92M | 5.08M | 4.59M | 3.90M | 3.16M | 3.98M | 4.95M | 4.06M | 3.94M | 3.21M | 3.40M | 3.00M | 3.10M | 6.30M | 2.20M |
| Cost & Expenses | 7.39M | 7.96M | 9.85M | 8.80M | 8.79M | 6.64M | 7.48M | 9.23M | 6.86M | 7.70M | 5.81M | 5.17M | 3.90M | 3.70M | 7.70M | 3.00M |
| Interest Income | 502.00 | 1.06K | 3.68K | 45.58K | 71.73K | 96.70K | 4.46K | 7.81K | 9.69K | 15.38K | 39.42K | 47.98K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 14.70K | 6.12K | 5.32K | 1.47K | 3.50K | 31.42K | 102.13K | 95.74K | 58.71K | 3.02K | 93.48K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 41.61K | 99.59K | 198.09K | 160.00K | 96.37K | 50.91K | 64.64K | 66.19K | 40.79K | 47.05K | 43.58K | 40.20K | -200.00K | 100.00K | 100.00K | 0.00 |
| EBITDA | -430.00K | -655.71K | -1.73M | -1.83M | -1.26M | -376.58K | -1.98M | -2.35M | -1.36M | -2.54M | 383.26K | -1.29M | -2.00M | -2.60M | -4.20M | 100.00K |
| EBITDA Ratio | -6.25% | -9.16% | -20.73% | -18.82% | -17.24% | -69.02% | -36.28% | -32.63% | -24.96% | -49.52% | 6.24% | -36.51% | -95.24% | -280.00% | -123.53% | 3.23% |
| Operating Income | -474.22K | -760.36K | -1.94M | -2.04M | -1.36M | -427.48K | -2.04M | -2.42M | -1.40M | -2.58M | 339.68K | -1.33M | -1.80M | -2.70M | -4.30M | 100.00K |
| Operating Income Ratio | -6.86% | -10.56% | -24.27% | -28.19% | -18.32% | -6.88% | -37.47% | -35.61% | -25.71% | -50.44% | 5.53% | -34.55% | -85.71% | -270.00% | -126.47% | 3.23% |
| Total Other Income/Expenses | -12.09K | -1.07K | 2.61K | 45.40K | 84.68K | 3.97M | -97.68K | -87.92K | -49.02K | 12.36K | -54.06K | 163.55K | 300.00K | 200.00K | 0.00 | 100.00K |
| Income Before Tax | -486.31K | -761.42K | -1.94M | -1.99M | -1.28M | 3.55M | -2.14M | -2.51M | -1.45M | -2.57M | 285.63K | -1.16M | -1.50M | -2.50M | 0.00 | 200.00K |
| Income Before Tax Ratio | -7.03% | -10.57% | -24.24% | -27.56% | -17.18% | 57.12% | -39.26% | -36.91% | -26.61% | -50.20% | 4.65% | -30.29% | -71.43% | -250.00% | 0.00% | 6.45% |
| Income Tax Expense | 14.70K | 6.12K | -261.85K | 1.47K | -84.68K | 1.28M | -1.50M | 8.79K | 0.00 | 0.00 | 0.00 | -206.08K | -300.00K | -200.00K | 0.00 | 100.00K |
| Net Income | -486.31K | -761.42K | -1.68M | -1.99M | -1.28M | 2.27M | -634.08K | -2.52M | -1.45M | -2.57M | 285.63K | -957.57K | -1.20M | -2.50M | -4.30M | 100.00K |
| Net Income Ratio | -7.03% | -10.57% | -20.96% | -27.56% | -17.18% | 36.54% | -11.65% | -37.04% | -26.61% | -50.20% | 4.65% | -24.93% | -57.14% | -250.00% | -126.47% | 3.23% |
| EPS | -0.02 | -0.05 | -0.11 | -0.15 | -0.10 | 0.19 | -0.06 | -0.25 | -0.20 | -0.42 | 0.05 | -0.21 | -0.26 | -0.55 | -1.24 | 0.05 |
| EPS Diluted | -0.02 | -0.05 | -0.11 | -0.15 | -0.10 | 0.17 | -0.06 | -0.25 | -0.20 | -0.42 | 0.04 | -0.21 | -0.26 | -0.53 | -0.91 | 0.04 |
| Weighted Avg Shares Out | 19.55M | 16.15M | 14.97M | 13.66M | 13.31M | 11.91M | 10.24M | 10.23M | 7.09M | 6.08M | 5.47M | 4.59M | 4.55M | 4.55M | 3.47M | 2.00M |
| Weighted Avg Shares Out (Dil) | 19.55M | 16.15M | 14.97M | 13.66M | 13.31M | 13.40M | 10.24M | 10.23M | 7.09M | 6.08M | 6.48M | 4.59M | 4.65M | 4.72M | 4.71M | 2.50M |
Source: https://incomestatements.info
Category: Stock Reports